1. Home
  2. REKR vs ONCY Comparison

REKR vs ONCY Comparison

Compare REKR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

HOLD

Current Price

$0.71

Market Cap

96.5M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.95

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REKR
ONCY
Founded
2017
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Pharmaceuticals and Biotechnology
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.5M
98.7M
IPO Year
2017
2002

Fundamental Metrics

Financial Performance
Metric
REKR
ONCY
Price
$0.71
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
2.0M
1.6M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
N/A
EPS
N/A
N/A
Revenue
$9,234,000.00
N/A
Revenue This Year
$12.51
N/A
Revenue Next Year
$23.49
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.56
52 Week High
$3.42
$1.51

Technical Indicators

Market Signals
Indicator
REKR
ONCY
Relative Strength Index (RSI) 43.51 56.31
Support Level $0.70 $0.94
Resistance Level $0.92 $1.14
Average True Range (ATR) 0.04 0.07
MACD -0.00 0.01
Stochastic Oscillator 18.78 41.60

Price Performance

Historical Comparison
REKR
ONCY

About REKR Rekor Systems Inc.

Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: